EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Why kiss‐and‐hop explains that tau does not stabilize microtubules and does not interfere with axonal transport (at physiological conditions)

Lidia Bakota, Roland Brandt iD

Cytoskeleton · 2024-01 · 81 (1) · 47-52

DOI: 10.1002/cm.21787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytoskeleton, online erschienen am 11.09.2023. Verfasst von Lidia Bakota und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, School of Biology/Chemistry, Osnabrück University, Osnabrück, Germany. Hauptthemen laut MEDLINE: tau Proteins, Tauopathies. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tau is a microtubule‐associated protein that is enriched in the axonal process of neurons. Post‐translational modifications of tau have been implicated in the development of tauopathies characterized by defects in axonal transport, neuronal atrophy, and microtubule disassembly. Although tau is almost quantitatively bound to microtubules under physiological conditions, it does not significantly affect axonal transport. Furthermore, acute or chronic tau deficiency does not result in significant destabilization of neuronal microtubules, challenging the classical view that disease‐related tau modifications directly cause axonal microtubule collapse. Here, we discuss how the rapid interaction kinetics of the tau‐microtubule interaction, which we previously termed the kiss‐and‐hop interaction, explains why tau does not affect microtubule‐dependent axonal transport but still allows tau to modulate microtubule polymerization. In contrast, tau modifications that slow down the kinetics of the tau‐microtubule interaction and increase the residence time of tau at a microtubule interaction site can disrupt axonal transport and cause dendritic atrophy. We discuss the consequences of such a gain‐of‐toxicity mechanism in terms of the development of disease‐modulating drugs that target the tau protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsTauopathiesHumansAxonal TransportMicrotubulesAtrophy

Stichwörter der Autor:innen

MAPaxonal transportmicrotubulestautauopathies

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Department of Neurobiology, School of Biology/Chemistry, Osnabrück University, Osnabrück, Germany.
  • Center for Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany.
  • Institute of Cognitive Science, Osnabrück University, Osnabrück, Germany.

ORCID-Profile: Roland Brandt

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Bakota, L., & Brandt, R. (2024). Why kiss‐and‐hop explains that tau does not stabilize microtubules and does not interfere with axonal transport (at physiological conditions). Cytoskeleton, 81(1), 47-52. https://doi.org/10.1002/cm.21787

Vancouver

Bakota L, Brandt R. Why kiss‐and‐hop explains that tau does not stabilize microtubules and does not interfere with axonal transport (at physiological conditions). Cytoskeleton. 2024;81(1):47-52. doi:10.1002/cm.21787

BibTeX
@article{Bakota2024,
  author = {Bakota, Lidia and Brandt, Roland},
  title = {Why kiss‐and‐hop explains that tau does not stabilize microtubules and does not interfere with axonal transport (at physiological conditions)},
  journal = {Cytoskeleton},
  year = {2024},
  volume = {81},
  number = {1},
  pages = {47--52},
  doi = {10.1002/cm.21787}
}
Kostenlos starten →